Literature DB >> 26053729

Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT.

Ismaheel Lawal1, Mariza Vorster, Tebatso Boshomane, Kehinde Ololade, Thomas Ebenhan, Mike Sathekge.   

Abstract

We describe the finding of a metastatic superscan detected by Ga-PSMA PET/CT imaging. A 63-year-old man with metastatic prostate carcinoma underwent Ga-PSMA PET/CT imaging for staging and evaluation of the most appropriate therapeutic option. Images demonstrated diffuse and extensive skeletal uptake in the axial and appendicular skeleton, corresponding to the typical red marrow distribution. Intense soft tissue uptake was also seen in the prostate and multiple pelvic and abdominal lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053729     DOI: 10.1097/RLU.0000000000000870

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.

Authors:  Ansje S Fortuin; Roger Brüggemann; Janine van der Linden; Ilia Panfilov; Bas Israël; Tom W J Scheenen; Jelle O Barentsz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-04-06

2.  Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT: A case report.

Authors:  Ismaheel Lawal; Alfred Ankrah; Kehinde Ololade; Moshe Modiselle; Mike Sathekge
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

Review 3.  Metal-Based PSMA Radioligands.

Authors:  Eleni Gourni; Gjermund Henriksen
Journal:  Molecules       Date:  2017-03-24       Impact factor: 4.411

4.  Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan.

Authors:  Krishan Kant Agarwal; Madhavi Tripathi; Rajeev Kumar; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun

Review 5.  Global experience with PSMA-based alpha therapy in prostate cancer.

Authors:  Mike M Sathekge; Frank Bruchertseifer; Mariza Vorster; Alfred Morgenstern; Ismaheel O Lawal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-26       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.